Gondois-Rey, F., Biancotto, A., Fernandez, M. A., Bettendroffer, L., Blazkova, J., Trejbalova, K., . . . Hirsch, I. (2006). R5 Variants of Human Immunodeficiency Virus Type 1 Preferentially Infect CD62L(−) CD4(+) T Cells and Are Potentially Resistant to Nucleoside Reverse Transcriptase Inhibitors. American Society for Microbiology.

Gondois-Rey, Françoise, Angelique Biancotto, Marcelo Antonio Fernandez, Lise Bettendroffer, Jana Blazkova, Katerina Trejbalova, Marjorie Pion, and Ivan Hirsch. R5 Variants of Human Immunodeficiency Virus Type 1 Preferentially Infect CD62L(−) CD4(+) T Cells and Are Potentially Resistant to Nucleoside Reverse Transcriptase Inhibitors. American Society for Microbiology, 2006.

Gondois-Rey, Françoise, et al. R5 Variants of Human Immunodeficiency Virus Type 1 Preferentially Infect CD62L(−) CD4(+) T Cells and Are Potentially Resistant to Nucleoside Reverse Transcriptase Inhibitors. American Society for Microbiology, 2006.